Today, we proudly launch the UP2Stars acceleration program at INNOVIT - Italian Innovation and Culture Hub in San Francisco. This initiative, created through a partnership between INNOVIT and Intesa Sanpaolo — Italy's largest bank and a committed supporter of startups — with the vital support of Intesa Sanpaolo Innovation Center, aims to boost the growth and internationalization of some of Italy’s most promising startups. Throughout this week-long program, these startups will engage in intensive mentorship sessions, connect with industry experts, and build networks with potential international investors. This is a unique chance to immerse themselves in the vibrant Silicon Valley ecosystem and elevate Italian innovation on the global stage. Stay tuned as we share updates on how these Italian startups are set to make their impact! #UP2Stars #IntesaSanpaolo #IntesaSanpaoloInnovationCenter #INNOVIT #SiliconValley
INNOVIT - Italian Innovation and Culture Hub
Government Relations Services
San Francisco, California 8,425 followers
Bringing the best of Italy together – technology, culture, and science – in a one-of-a-kind space for global innovation
About us
INNOVIT is a technological outpost in Silicon Valley home to the world’s largest high-tech community. A strategic Hub for the promotion of the Italian economic, scientific, and cultural ecosystem in the United States. It is a place that inspires innovative entrepreneurial ideas and cross-cultural initiatives and serves as an accelerator for their international development. INNOV.IT’s goal is to create a powerful partnership between the American and Italian economic and cultural ecosystems, and ensure these Italian communities have a long-lasting presence in Silicon Valley. INNOVIT is strategic project promoted by the Italian Ministry of Foreign Affairs and International Cooperation under the proposal of the Embassy of Italy in Washington and in collaboration with the Italian Consulate General in San Francisco and it is implemented thanks to the involvement of the ITA – Italian Trade Agency and the IIC – Italian Cultural Institute San Francisco. OUR MISSION To support the development of a culture of innovation within the Italian technology ecosystem, providing connections, content and inspiration to Italian stakeholders such as startups, accelerators, incubators, universities, research centres, public agencies, investors, mentors, talents. To learn from the best practices of Silicon Valley, and the world, and infuse that knowledge within the Italian tech community, accelerating Italy’s growth as a technologically forward country. To connect Italy with the world’s innovation hotspots, in order to create opportunities for networking and international development of the Italian tech community resulting in new job opportunities, sustainable growth and cultural enrichment.
- Website
-
http://www.innovitsf.com
External link for INNOVIT - Italian Innovation and Culture Hub
- Industry
- Government Relations Services
- Company size
- 2-10 employees
- Headquarters
- San Francisco, California
- Type
- Government Agency
Locations
-
Primary
710 Sansome St
San Francisco, California 94111, US
Employees at INNOVIT - Italian Innovation and Culture Hub
-
Alessandro Zago
Venture Capital | Global Business Development | Corporate Development | Innovation | Technology | Automotive | Industrial | Energy |…
-
Leandro Agro'
Design & Innovation Executive, spatial computing/immersive tech, IoT pioneer, books author and patents contributor.
-
Sebastiano Peluso
Head of Innovation Desk @ Italian Trade Agency, Founder @ Realitycs 3040 Regeneration Discovery Italy Smartourism Sicilytime Isola.Catania,…
-
Alberto Acito
Director Italian Innovation Hub in San Francisco | Innovation, Entrepreneurship, Strategic Partnerships
Updates
-
Introducing InSilicoTrials, a pioneering force in #DrugDevelopment through advanced #Modeling and #Simulation technologies. They are recognized as the leading problem-solver in the field, leveraging #AI and #VirtualPatient models to accelerate the #DrugDevelopment process. InSilicoTrials offers a comprehensive #platform spanning all stages of drug development. It features a diverse array of models contributed by #academics, #researchers, and #regulatory bodies. Covering numerous #therapeutic areas, their platform supports both pre-clinical and #ClinicalTrials, utilizing #VirtualPatients representing varied #demographics and medical conditions to ensure #inclusivity. Explore how InSilicoTrials is reshaping drug development strategies at https://lnkd.in/dsgWah-K or get in contact with the CEO Luca Emili. #CostReduction #HealthcareInnovation
-
Introducing InSimili, dedicated to accelerating the development of effective therapies through advanced #InVitro models as the new standard for early #DrugScreening, revolutionizing #BiomedicalResearch. Their flagship product comprises a range of consumables designed for precise #OxygenRegulation within in vitro environments. This innovation ensures cells remain in a controlled #microenvironment throughout the experimental process, seamlessly integrating from the incubator to the analysis phase. Configurable, cost-effective, and validated for high throughput screening, it enhances efficiency while maintaining compatibility with standard #laboratory procedures. Discover how InSimili is transforming #DrugDiscovery and biomedical research at http://www.insimili.com/ or get in contact with Enrico Grassilli for further insights into their groundbreaking advancements. #TherapyDevelopment #LaboratoryInnovation
-
Introducing GEK Lab, a pioneer in precision and #PersonalizedMedicine. They specialize in advancing diagnostics for prediabetes and #GestationalDiabetes, offering integrated systems for #InflammationManagement. Their flagship product revolutionizes early detection with a #NonInvasive diagnostic approach using #InnovativeBiomarkers #Methylglyoxal and #GlycatedAlbumin. Coupled with personalized intervention plans driven by #LLM technology, their product facilitates first-trimester detection and continuous #monitoring, optimizing outcomes for expectant mothers. This solution not only enhances #EarlyDetection capabilities but also tailors treatment plans through seamless LLM integration, effectively reducing complications and healthcare expenses while improving #PatientCompliance and #health outcomes. Discover how GEK Lab is redefining Gestational Diabetes Management standards at http://www.geklab.com/ or get in contact with the founder and CEO Enrico Fiorentin. #PrecisionMedicine #HealthcareInnovation
-
Introducing COMFTECH srl, pioneers in health #DataCollection through comfortable #WearableMonitoring systems based on #SmartTextiles. HOWDY BABY, a #monitoring solution for #newborns, enables continuous tracking of #VitalSigns post-birth. It supports #ClinicalPersonnel by monitoring #heart rate, #breath rate, and body #position, facilitating prompt interventions when necessary. Digitalizing assessment forms and remote data access optimize #healthcare time management. With #NonInvasive, wireless textile technology and #MedicalData, this solution ensures comfort and safety for newborns, promoting essential skin-to-skin contact with mothers. #Patented textile sensors in the #UnitedStates highlight commitment to advancing healthcare through #InnovativeTechnology. Learn more about how ComfTech is redefining newborn care with technology at http://www.comftech.com/ or get in contact with the founder and CEO Alessia Moltani and the R&D Manager Davide Dal Castello. #NewbornCare #DigitalHealthcare
-
Introducing enGenome, your partner in advancing #healthcare through #genomics. Specializing in delivering precise genomic #reports for the diagnosis and treatment of #GeneticDiseases, enGenome is committed to revolutionizing #PersonalizedMedicine. At the heart of enGenome's offerings is eVai (Expert Variant Interpreter), a #SaaSPlatform renowned for its rapid and highly accurate interpretation of patient variants, which employs #AI and #bioinformatics to classify #GenomicVariants and propose potential genetic #diagnoses. Integrated seamlessly with VarChat, the GenAI-based genomic assistant, eVai provides instant access to detailed variant information and #ScientificInsights, enhancing #DiagnosticPrecision and clinical #DecisionMaking. Discover how enGenome is reshaping genomic interpretation and advancing healthcare solutions at http://www.engenome.com/ or get in contact with the co-founder and CEO Ettore Rizzo, PhD, MBA #HealthcareInnovation
-
Introducing Diamante Società Benefit Srl, a #biotechnology company advancing plant-based #PeptideDrugs for #AutoimmuneDiseases, aiming to re-educate the human #ImmuneSystem against self-attack. Their therapy for #RheumatoidArthritis has shown efficacy in animal models, achieving complete remission of arthritic symptoms with superior #ClinicalOutcomes compared to the standard treatments. This novel approach utilizes harmless plant viruses to deliver #immunomodulatory peptides, promoting early treatment while preserving immune function. The #PlantBased production system ensures greater safety, scalability, and cost-effectiveness in #DrugManufacturing. Explore more about DIAMANTE's innovative strides in autoimmune disease treatment: at http://www.diamante.com/ or get in contact with the CEO Co-Founder Valentina Garonzi. #InnovativeTherapies
-
Introducing ChemiCare | It's a rare thing to care, an innovative company pioneering #TherapeuticSolutions for diseases linked to Store Operated Calcium Entry, including #MuscularDystrophy and #AutoimmuneDisorders. Their lead projects, has shown promising efficacy across all muscular dystrophy mutations in #PreclinicalStudies and boasts an excellent safety profile. With existing treatments primarily targeting specific mutations, leaving many patients without options, ChemiCare aims to revolutionize #treatment options with its unique #SmallMolecule approach to #CalciumIonModulation. Explore more about ChemiCare's groundbreaking initiatives at http://www.chemicare.com/ or get in contact with Beatrice Riva and Luigi Azzarone.
-
Dear Innovators, Join us at our webinar, focused on the Call4INNOVIT - this time about #SpaceEconomy! This is a unique opportunity for Italian #startups in the field to explore how #INNOVIT can unlock international #opportunities and support their global success. Our #AccelerationProgram in #SanFrancisco (November 18-22, 2024) offers intensive #mentorship, direct #networking with international investors in the field, and high #visibility for your innovative ideas. Apply by October 3rd, 2024, to take advantage of this exceptional opportunity. Stay tuned for more updates on speakers and the full agenda! Register here: https://lu.ma/swcc9z4s
-
Introducing Develop-Players, transforming #Neurodevelopmental disorders assessment and treatment through serious #Games, enhancing accessibility and reducing costs for #children aged 5 to 16. Their web platform offers families swift access to #diagnostic and #treatment pathways via #GameBased, #AI driven approaches for all neurodevelopmental disorders, making treatments more #CostEffective, accessible, and #ChildFriendly compared to traditional methods. Explore how Develop-Players is reshaping neurodevelopmental disorder care at https://lnkd.in/dDDa9PeU or get in contact with Luca Formica, Founder and CEO, and Mariagrazia Benassi, Founder and CPO. #ChildAssessment #AccessibleHealthcare #PersonalizedCare #DigitalHealth